SynthesisStem cell research & therapy2022

Safety, efficacy and biomarkers analysis of mesenchymal stromal cells therapy in ARDS: a systematic review and meta-analysis based on phase I and II RCTs.

Jianbao Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.